Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-11-27
1994-03-08
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
540460, 548433, A01N 4390, C07D48702
Patent
active
052927652
ABSTRACT:
A method for reducing adverse effects of neurotoxic injury, which comprises administering to a patient susceptible to neurotoxic injury an effective amount, sufficient to reduce the injury, of a compound having an indolactam V ring system. Particularly preferred are compounds having ring stereochemistry as indicated in the following formula: ##STR1## The indicated substituents show preferred locations of substituents; preferred substituents are defined in the specification.
REFERENCES:
patent: 5089517 (1992-02-01), Choi et al.
patent: 5110811 (1992-05-01), Okuhara et al.
patent: 5177101 (1993-01-01), Glamkowski et al.
patent: 5229409 (1993-07-01), Flaugh et al.
Rothman, S., "Synaptic Release of Excitatory Amino Acid Neurotransmitter Mediates Anoxic Neuronal Death", J. Neurosci. (1984) 4:1884-1891).
Simon, R. P., et al., "Blockade of N-methyl-B-aspartate Receptors May Protect Against Ischemic Damage in the Brain", Science (1984) 226:850-852).
Weiloch, T., "Hypoglycemia-Induced Neuronal Damage Prevented by an N-methyl-D-aspartate Antagonist", Science (1985) 230:681-683.
Choi, D., "Glutamate neurotoxicity and diseases of the nervous system" Neuron (1988) 1:623-634.
Harata et al., Bull. Chem. Soc. Japan (1966) 39:1773-1775.
Irie et al., Int. J. Cancer (1985) 36:485-488.
Fujiki et al. Proc. Japan Acad., Ser. D, (1985) 61:45-47.
Horiuchi et al., Gann. (1984) 75:837-840.
Irie and Coshimizu Mem. Coll. Agric., Kyoto Univ., (1988) 132:1-59.
(Jan. 1990) New Products Bulletin of L.C. Services Corporation, Woburn, Mass.
Muratake, et al., Tetrahedran Lett. (1987), 28:2265-2268.
Muratake, et al., Tetrahedran Lett. (1988), 29:6267-6270.
Okabe, et al., Chem. Pharm. Bull. (1989), 37:563-564.
Choi Dennis W.
Hartley Dean M.
Burn B.
Hollrah Glennon H.
The Board of Trustees of the Leland Stanford Junior University
LandOfFree
Neuroprotection by indolactam V and derivatives thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neuroprotection by indolactam V and derivatives thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuroprotection by indolactam V and derivatives thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-153739